Transgene's total assets for Q2 2026 were €124.53M, a decrease of -10.30% from the previous quarter. DE:TGNA total liabilities were €15.33M for the fiscal quarter, a -10.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.